Interpace Biosciences Inc Vállalati érték
Mi az Interpace Biosciences Inc Vállalati érték?
A Vállalati érték az Interpace Biosciences Inc - $1.32M
Mi a Vállalati érték meghatározása?
A vállalati érték a vállalat teljes piaci értékének mértéke. A piaci kapitalizáció az adósság, a kisebbségi részesedés és a preferált részvények összege, a pénzeszközök és pénzeszköz-egyenértékek összege mínusz.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Vállalati érték a Health Care szektor a NASDAQ-on cégekben a Interpace Biosciences Inc -hoz képest
Mit csinál Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
vállalati érték -hoz hasonló cégek Interpace Biosciences Inc
- Factor Therapeutics nak Vállalati érték $1.31M van
- Quark Technology Global nak Vállalati érték $1.31M van
- Fintech Select nak Vállalati érték $1.31M van
- Life On Earth nak Vállalati érték $1.31M van
- Tymbal Resources nak Vállalati érték $1.31M van
- Goldstar Minerals nak Vállalati érték $1.32M van
- Interpace Biosciences Inc nak Vállalati érték $1.32M van
- Wescan Goldfields nak Vállalati érték $1.32M van
- Inspirit Plc nak Vállalati érték $1.32M van
- ThreeD Capital nak Vállalati érték $1.32M van
- NEXE Innovations nak Vállalati érték $1.33M van
- Softrock Minerals nak Vállalati érték $1.33M van
- Aurum Resources Ltd nak Vállalati érték $1.33M van